The success and longevity of the forum is built on the goodwill and repeat attendance of major corporate and financial investors, and pharma licensing executives and advisors, who are seeking to network with biotechs. The programme and presentations allow all to keep up with the latest industry developments and strategize for 2023. The physical programme will consist of the usual panels and keynotes, which will be available on demand from the 8th of March. Additionally, there will be pre-arranged in-person meetings, live and on demand company showcases and a reception. During the online week, virtual meetings will be available through the audio/video online meeting system.
The main programme for the 16th Annual ELSF is spread throughout 2 days (1st – 2nd of March) and will feature more than 12 hours of high-level keynotes and panel discussions. In addition, there will be a global company showcase of 50+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated presentation tracks, alongside virtual company showcases, which will be available on demand during the virtual week. We anticipate 400+ delegates will register for the forum from all Life Sciences sectors, with the target audience being corporate and financial investors/partners, banks and advisors with part of the audience participating virtually.
The In-Person meetings will be taking place on the March, while virtual meetings will take place on the 8th – 10th of March. For the virtual meetings, the system will allow you to have a secure audio/video call, as well as option to present slides using a screen share function and we will have a dedicated room for in-person meetings. We expect 2000+ meetings completed during SSLSW. The conference will be held in the Central European Time Zone. The programme will consist of:
- Prospects for Biopharma in 2023 Panel
- Outlook for Global Venture & Private Equity Panel
- Platform & New Technologies Panel
- Cell & Gene Therapies: Latest Therapeutic Advances Panel
- Raising Capital Markets Panel
- Neuro Advances Panel
- Pharma Dealmakers Roundtable
- Latest Trends in Oncology BD&L Panel
- Oncology Advanced Therapeutics Panel
- Early Stage Investor Panel
- Presenting Company Session: Biopôle Selected Investment Opportunities
- Rising Biotech Stars Session
Hotel Hilton Zurich Airport Opfikon